Every investor dreams of picking the big movers before they take off – the next Amazon, Intel, or Netflix. The surest way to fail at this is to buy after everybody else has loaded up on a stock; the surest way to succeed is by conducting deep research, analyzing the data, and waiting patiently until a rare opportunity presents itself.

It’s a process that can’t be rushed or forced, and it requires the time and resources that most retail investors don’t have. Thankfully, I’ve got the Wealth Research Group team of full-time analysts by my side, crunching the numbers and consistently picking the winners before they double or triple in price.

The approach that we take to investing is very different from most analysts, who give out new “hot stock picks” every day with no regard for the end result. The Wealth Research Group methodology is quite unique: our signals don’t get triggered often, but when they do, it’s powerful because it’s backed by massive due diligence that’s typically months in the making.

Our most recent signal came from the CBD (cannabidiol) sector, which is hugely popular in this new era of cannabis acceptance and decriminalization. An in-demand commodity and one of the most remarkable compounds in the natural world, CBD oils are the fully legal, non-psychoactive part of the cannabis plant. Unlike THC-based products, CBD oils and extracts are able to be bought, sold, owned, and used in every state in the U.S.

Millennials are a big part of the CBD consumer base, as they are very mindful of their health and appreciate the benefits that these products can provide. This is currently being reflected in strong sales for healthy, CBD-infused products:

Courtesy of Hemp Business Journal

Just in the United States, CBD sales will expand into the billions of dollars in the coming years; in Canada and around the world, CBD products are also showing strong sales across multiple demographics.

With more and more consumers insisting on healthy products and asking about the many benefits of CBD’s, Wealth Research Group has been scouring the markets for ways to profit from these fresh industry trends. Of course, we only invest our money in companies that have plenty of available capital, great leadership, little or no debt, and a unique product or service in their industry.

Next, we narrow down the candidates even further by eliminating the expensive or overpriced stocks; if we like a particular company, we’ll wait until it hits a more attractive price point. After sifting through hundreds of companies, the clear choice right now is KOIOS Beverage Corp. (CSE:KBEV, OTC:KBEVF) because of its perfect positioning in the CBD and health-product markets.

With a wide selection of delicious and healthy beverages and supplements, KOIOS products utilize 11 ingredients specifically designed to enhance brain function. This company’s unique proprietary nutritional blends provide multiple brain-boosting benefits without sugar, caffeine, or chemicals:

Courtesy of KOIOS Beverage Corp. Investor Presentation

KOIOS captures the best elements of multiple niche markets that are in full bloom in 2018: the nootropics market (supplements or other substances that improve cognitive function, a market that will grow by a CAGR of 17.9% to $6 billion in 2024); the CBD market; and the functional beverages market, which will expand by a CAGR of 7.4% to $105.5 billion by 2021.

Wealth Research Group is accumulating shares of KBEV/KBEVF because it’s trading at a particularly attractive price point right now. Right now is a great time to enter into the explosive CBD and healthy beverage markets with a position in KOIOS Beverage Corp. To get our complete report on the big moves that this company is making in 2018, simply go here to get immediate access via our convenient download page.

Best Regards,

Lior Gantz
President, WealthResearchGroup.com

Legal Notice: This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

Never base any decision off of our emails. WealthResearchGroup.com stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish.  Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have entered into an agreement for three hundred thousand dollars and five hundred thousand options paid for directly by the company. We have also purchased shares and are long the company. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at WealthResearchGroup.com.